Psoriatic Disease

Psoriasis has a substantial psychological burden that affects quality of life for many patients, according to a presentation at the European Academy of Dermatology and Venereology virtual congress.

In a real-world cohort of more than 2,000 U.S. patients with psoriatic arthritis, most had multidomain presentations, which were associated with worse disease activity, quality of life and work productivity, according to data published in The Journal of Rheumatology.

Latent tuberculosis infection was an uncommon adverse event after treatment with secukinumab for chronic systemic inflammatory conditions, according to a study published in JAMA Dermatology.

Healio Psoriatic Disease, the first publication focused on informing health care professionals about the burden of psoriatic disease and the understanding of psoriasis as a systemic disease, has named Joel M. Gelfand, MD, MSCE, as its Chief Medical Editor.

Novel therapies are providing hope for more targeted therapy options in managing the myriad manifestations of psoriatic arthritis, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.

Psoriatic arthritis and gout often present with similar symptoms and radiological signs, an overlap that may be more significant when these diseases occur concomitantly, noted a presenter at the 2020 Congress of Clinical Rheumatology-West.

A twice-weekly dose of topical calcipotriene and betamethasone dipropionate increased the time in plaque psoriasis remission in the phase 3 PSO-LONG trial, according to a study published in Journal of the American Academy of Dermatology.

Treatment of psoriatic conditions or Crohn’s disease with ustekinumab was associated with severe cardiovascular events in certain high-risk patients, according to a study.

A psoriatic microenvironment score could help predict how some psoriatic lesions will respond to certain treatments, allowing practitioners to reduce exposure to ineffective therapies, according to a study.

Patients with psoriasis, as well as their family members, experience multiple negative impacts to their quality of life due to the disease, according to a poster presented at the American Academy of Dermatology virtual meeting.